CAS 212625-79-1
:pyrrolidine-2,2,3,3,4,4,5,5-D8
Description:
Pyrrolidine-2,2,3,3,4,4,5,5-D8 is a deuterated form of pyrrolidine, a five-membered saturated heterocyclic compound. The presence of deuterium atoms, which are isotopes of hydrogen, enhances its stability and alters its physical properties, making it useful in various applications, particularly in NMR spectroscopy and studies involving isotopic labeling. This compound typically exhibits characteristics similar to those of non-deuterated pyrrolidine, such as being a colorless liquid with a characteristic amine-like odor. It is soluble in water and organic solvents, and its molecular structure includes a nitrogen atom within the ring, contributing to its basicity. The deuteration can affect the compound's reactivity and interaction with other substances, making it valuable in research settings, particularly in the fields of organic chemistry and pharmacology. Safety data should be consulted for handling and storage, as with any chemical substance, to ensure proper precautions are taken.
Formula:C4HD8N
InChI:InChI=1/C4H9N/c1-2-4-5-3-1/h5H,1-4H2/i1D2,2D2,3D2,4D2
SMILES:C1(C(C(NC1([2H])[2H])([2H])[2H])([2H])[2H])([2H])[2H]
Synonyms:- 2,2,3,3,4,4,5,5-Octadeuteriopyrrolidine
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 3 products.
Pyrrolidine-2,2,3,3,4,4,5,5-d8
CAS:Purity:98 atom % DColor and Shape:Colourless-Pale Yellow LiquidMolecular weight:79.17Pyrrolidine-d8
CAS:Controlled Product<p>Applications Labelled analogue of Pyrrolidine, a heterocyclic compound used as a building block in the synthesis of wide range of pharmaceutical compounds, namely matrix metalloprotein inhibitors (MMPIs) and aminopeptidase N inhibitors (APNIs).<br>References Li, X. et al.: Mini-Rev. Med. Chem., 10, 794 (2010); Gragutan, I. et al.: Beil. J. Org. Chem., 7, 699 (2011);<br></p>Formula:C4D8HNColor and Shape:NeatMolecular weight:79.17Pyrrolidine-2,2,3,3,4,4,5,5-d8
CAS:Formula:C4HD8NPurity:98%Color and Shape:LiquidMolecular weight:79.1703


